Nepstar Acquires 18 Chain Drugstores
This article was originally published in PharmAsia News
After purchasing 68 drugstores in February, Nepstar has made its second acquisition after listing overseas, buying Huirentang's 18 chain drugstores in Dongguan, Guangdong province, for 2.3 million yuan ($324,373). Nepstar will speed up its merger and acquisition activities this year, targeting the opening of 1,050 new shops, especially in the Zhujiang Delta area. According to the company's listing plan, funds raised will be channeled into the setup of a distribution center, an enterprise resource planning system and chain drugstore expansion; inside sources revealed that the capital will be mainly used to increase the number of shops, particularly in high entry-level cities such as Beijing and Shanghai. The firm recently invested substantially in a new SAP ERP system. (Click here for more - Chinese Language)
You may also be interested in...
Pierre Bourdage, global head of biopharmaceuticals at Sandoz, has hit back at false statements and misleading claims around biosimilars that persist despite mounting evidence to the contrary.
A recent Spanish self-care and cosmetics industry conference organized by ANEFP and Beauty Cluster explores the commercial opportunity in China via online marketplace Tmall.
Australia’s NeuClone expects to be among the first biosimilar market entrants to challenge Stelara, with the firm’s NeuLara ustekinumab rival reporting positive Phase I data as the company prepares to move ahead with Phase III trials next year.